EMAIL THIS PAGE TO A FRIEND

Postgraduate medicine

Anti-diabetes therapy: safety considerations for patients with impaired kidney function.


PMID 24918801

Abstract

The presence of type 2 diabetes mellitus (T2DM) is a common risk factor for the development of chronic kidney disease, but appropriate glycemic control can slow the progression of kidney dysfunction in patients with T2DM. The kidney plays a role in insulin resistance and gluconeogenesis, therefore, impaired kidney function alters glucose dynamics compared with normal kidney function, thus affecting antihyperglycemic treatment strategies. Glycemic management is further complicated by reduced drug clearance and a greater risk of hypoglycemia with use of certain medications, notably the sulfonylureas. Of the classes of antihyperglycemic drugs discussed in this review, caution is advised when using some classes in patients with T2DM and kidney disease.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

36147
Mecoprop, PESTANAL®, analytical standard
C10H11ClO3